Investment area

Bioindustrial Investments

Growth Investments



Date of investment

April 2021

AMSilk is the world's first industrial supplier of smart biotech materials based on silk proteins for a variety of applications such as textile fibers, medical devices and consumer goods.

Visit site


Anders Bendsen Spohr

Senior Partner, Head of Bioindustrial Investments

Departments: Bioindustrial Investments, Life Sciences Operating Committee

Anders joined Novo Holdings A/S in 2017.
Anders is Sr Partner and Head of the Bioindustrial investments team.

Prior to joining Novo Holdings, Anders was employed as VP in Xellia Pharmaceuticals heading up the Global Product Supply. Other previous employments include EVP, Global Product Supply at Leo Pharma A/S and VP Global Supply Chain at Novozymes A/S.

Anders holds a PhD in Biotechnology and a MSc in Chemical Engineering from Technical University of Denmark as well as a graduate diploma in Business Administration (International Business) from Copenhagen Business School.


Marcus Remmers


Department: Bioindustrial Investments

Marcus joined Novo Holdings A/S in October 2022 as Partner in the Bioindustrials Team taking part in managing and developing the growing portfolio of investments.

Marcus has more than 25 years of experience with several senior leadership roles across the globe having worked in the US, Germany, Mexico, Austria and the UK. Previously, he was Chief Technology Officer at Royal DSM and prior to that held various positions in the Animal Health Industry including leadership of Biologics and Pharma R&D, global M&A licensing and Country President. Marcus is passionate about innovation and sustainability and also serves as a member of the Global Expert Network of the World Economic Forum.

Marcus holds a doctorate in Polymer Chemistry (1997) from the Max Planck Institute for Polymer Research and a Diploma in Chemistry from the University of Freiburg, Germany.